siRNA therapy lowers triglycerides in patients along with rare disorder
.STUDY FEATURE.19 September 2024.
Plozasiran lessened triglyceride amounts by 80% and also reduced the danger of pancreatitis in people with chronic chylomicronemia, along with or without a hereditary prognosis.